{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T04:06:02Z","timestamp":1751342762294,"version":"3.41.0"},"reference-count":62,"publisher":"Jaypee Brothers Medical Publishing","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.59556\/japi.72.0687","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:15:36Z","timestamp":1751274936000},"page":"58-62","source":"Crossref","is-referenced-by-count":0,"title":["Gluconephrotic Syndrome: A Comprehensive Review"],"prefix":"10.59556","volume":"72","author":[{"given":"Sourabh","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(2):","key":"key20250630091532_B1","doi-asserted-by":"crossref","first-page":"87\u2013","DOI":"10.1542\/pir.2020-001230","article-title":"Nephrotic syndrome.","volume":"43","author":"Rodriguez-Ballestas","year":"2022;","journal-title":"Pediatr Rev"},{"issue":"(1801):","key":"key20250630091532_B2","first-page":"11\u2013","article-title":"Diagnosis and management of nephrotic syndrome.","volume":"261","author":"McCloskey","year":"2017;","journal-title":"Practitioner"},{"issue":"(9):","key":"key20250630091532_B3","doi-asserted-by":"crossref","first-page":"607\u2013","DOI":"10.1016\/j.revmed.2020.05.007","article-title":"Corticosteroid-induced diabetes: novelties in pathophysiology and management.","volume":"41","author":"Bastin","year":"2020;","journal-title":"Rev Med Interne"},{"issue":"(9):","key":"key20250630091532_B4","first-page":"e29142.","article-title":"Stress-induced diabetes: a review.","volume":"14","author":"Sharma","year":"2022;","journal-title":"Cureus"},{"issue":"(2):","key":"key20250630091532_B5","doi-asserted-by":"crossref","first-page":"341\u2013","DOI":"10.1148\/radiology.153.2.6484164","article-title":"Diabetes mellitus: the predominant cause of bilateral renal enlargement.","volume":"153","author":"Segel","year":"1984;","journal-title":"Radiology"},{"issue":"(5):","key":"key20250630091532_B6","doi-asserted-by":"crossref","first-page":"840\u2013","DOI":"10.1053\/j.ajkd.2009.04.016","article-title":"Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition.","volume":"54","author":"Stoycheff","year":"2009;","journal-title":"Am J Kidney Dis"},{"issue":"(10):","key":"key20250630091532_B7","doi-asserted-by":"crossref","first-page":"1887\u2013","DOI":"10.1007\/s00467-016-3560-9","article-title":"Diabetes and nephrotic syndrome: answers.","volume":"32","author":"Gilbert","year":"2017;","journal-title":"Pediatr Nephrol"},{"issue":"(4):","key":"key20250630091532_B8","doi-asserted-by":"crossref","first-page":"1001\u2013","DOI":"10.1016\/j.mcna.2004.04.012","article-title":"Diabetic nephropathy and retinopathy.","volume":"88","author":"Jawa","year":"2004;","journal-title":"Med Clin North Am"},{"issue":"(6):","key":"key20250630091532_B9","doi-asserted-by":"crossref","first-page":"740\u2013","DOI":"10.1053\/j.ajkd.2022.04.005","article-title":"The risk of cardiovascular events in individuals with primary glomerular diseases.","volume":"80","author":"Canney","year":"2022;","journal-title":"Am J Kidney Dis"},{"issue":"(4):","key":"key20250630091532_B10","doi-asserted-by":"crossref","first-page":"546\u2013","DOI":"10.4103\/2230-8210.183480","article-title":"Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum?","volume":"20","author":"Chawla","year":"2016;","journal-title":"Indian J Endocrinol Metab"},{"issue":"(1):","key":"key20250630091532_B11","doi-asserted-by":"crossref","first-page":"52\u2013","DOI":"10.15420\/cfr.2016:20:2","article-title":"Heart failure in patients with diabetes mellitus.","volume":"3","author":"Rosano","year":"2017;","journal-title":"Card Fail Rev"},{"issue":"(6):","key":"key20250630091532_B12","doi-asserted-by":"crossref","first-page":"804\u2013","DOI":"10.4093\/dmj.2019.0071","article-title":"Diabetes and the risk of infection: a national cohort study.","volume":"43","author":"Kim","year":"2019;","journal-title":"Diabetes Metab J"},{"issue":"(Suppl 1):","key":"key20250630091532_B13","first-page":"S27\u2013","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis.","volume":"16","author":"Casqueiro","year":"2012;","journal-title":"Indian J Endocrinol Metab"},{"issue":"(7):","key":"key20250630091532_B14","doi-asserted-by":"crossref","first-page":"692\u2013","DOI":"10.1177\/0009922820908583","article-title":"Infections in children with nephrotic syndrome: twenty years of experience.","volume":"59","author":"Lebel","year":"2020;","journal-title":"Clin Pediatr (Phila)"},{"issue":"(4):","key":"key20250630091532_B15","doi-asserted-by":"crossref","first-page":"526\u2013","DOI":"10.1590\/2175-8239-jbn-2019-0001","article-title":"Incidence and risk factors for major infections in hospitalized children with nephrotic syndrome.","volume":"41","author":"Kumar","year":"2019;","journal-title":"J Bras Nefrol"},{"issue":"(6):","key":"key20250630091532_B16","doi-asserted-by":"crossref","first-page":"450\u2013","DOI":"10.4103\/0256-4947.57167","article-title":"Renal biopsy in patients with type 2 diabetes mellitus: indications and nature of the lesions.","volume":"29","author":"Ghani","year":"2009;","journal-title":"Ann Saudi Med"},{"issue":"(12):","key":"key20250630091532_B17","doi-asserted-by":"crossref","first-page":"2123\u2013","DOI":"10.1016\/j.numecd.2020.09.013","article-title":"Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society.","volume":"30","author":"Di Paolo","year":"2020;","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"(1):","key":"key20250630091532_B18","doi-asserted-by":"crossref","first-page":"193\u2013","DOI":"10.1113\/JP277002","article-title":"RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.","volume":"597","author":"Koszegi","year":"2019;","journal-title":"J Physiol"},{"issue":"(5):","key":"key20250630091532_B19","doi-asserted-by":"crossref","first-page":"141\u2013","DOI":"10.4239\/wjd.v1.i5.141","article-title":"Role of the renin angiotensin system in diabetic nephropathy.","volume":"1","author":"Chawla","year":"2010;","journal-title":"World J Diabetes"},{"issue":"(2):","key":"key20250630091532_B20","doi-asserted-by":"crossref","first-page":"189\u2013","DOI":"10.2174\/157016110790886947","article-title":"Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.","volume":"8","author":"Hayashi","year":"2010;","journal-title":"Curr Vasc Pharmacol"},{"issue":"(Suppl 2):","key":"key20250630091532_B21","doi-asserted-by":"crossref","first-page":"S165\u2013","DOI":"10.2337\/dcS15-3006","article-title":"SGLT2 inhibitors and the diabetic kidney.","volume":"39","author":"Fioretto","year":"2016;","journal-title":"Diabetes Care"},{"issue":"(7):","key":"key20250630091532_B22","doi-asserted-by":"crossref","first-page":"1995.","DOI":"10.3390\/pharmaceutics15071995","article-title":"SGLT2 inhibitors in the treatment of diabetic kidney disease: more than just glucose regulation.","volume":"15","author":"Klen","year":"2023;","journal-title":"Pharmaceutics"},{"key":"key20250630091532_B23","doi-asserted-by":"crossref","first-page":"967.","DOI":"10.3389\/fphar.2020.00967","article-title":"GLP-1 receptor agonists in diabetic kidney disease: from clinical outcomes to mechanisms.","volume":"11:","author":"Kawanami","year":"2020;","journal-title":"Front Pharmacol"},{"key":"key20250630091532_B24","doi-asserted-by":"crossref","first-page":"100502.","DOI":"10.1016\/j.ajpc.2023.100502","article-title":"Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: a review of their kidney and heart protection.","volume":"14:","author":"Michos","year":"2023;","journal-title":"Am J Prev Cardiol"},{"issue":"(1):","key":"key20250630091532_B25","doi-asserted-by":"crossref","first-page":"14.","DOI":"10.1186\/s12933-020-01197-z","article-title":"Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis.","volume":"20","author":"Yamada","year":"2021;","journal-title":"Cardiovasc Diabetol"},{"issue":"(2):","key":"key20250630091532_B26","doi-asserted-by":"crossref","first-page":"183\u2013","DOI":"10.1093\/ehjcvp\/pvad001","article-title":"Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.","volume":"9","author":"Filippatos","year":"2023;","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"(16):","key":"key20250630091532_B27","first-page":"V07220460.","article-title":"Management of amlodipine-induced ankle oedema.","volume":"185","author":"Skovbjerg","year":"2023;","journal-title":"Ugeskr Laeger"},{"issue":"(5):","key":"key20250630091532_B28","doi-asserted-by":"crossref","first-page":"1066\u2013","DOI":"10.1016\/j.kint.2019.07.003","article-title":"\u201dPermissive AKI\u201d with treatment of heart failure.","volume":"96","author":"Parikh","year":"2019;","journal-title":"Kidney Int"},{"issue":"(10):","key":"key20250630091532_B29","doi-asserted-by":"crossref","first-page":"1347\u2013","DOI":"10.34067\/KID.0000000000000266","article-title":"The mounting evidence for permissive hypercreatinemia in acute heart failure: adding sodium glucose cotransporter inhibitors to the list.","volume":"4","author":"Macedo","year":"2023;","journal-title":"Kidney360"},{"issue":"(10):","key":"key20250630091532_B30","doi-asserted-by":"crossref","first-page":"E506.","DOI":"10.1503\/cmaj.121232","article-title":"Peripheral edema with pregabalin.","volume":"185","author":"Gallagher","year":"2013;","journal-title":"CMAJ"},{"issue":"(4):","key":"key20250630091532_B31","doi-asserted-by":"crossref","first-page":"1535\u2013","DOI":"10.1007\/s13300-019-0654-y","article-title":"Differential effect of hypoalbuminemia on hypoglycemia on type 2 diabetes patients treated with insulin glargine 300 U\/ml and insulin degludec.","volume":"10","author":"Kawaguchi","year":"2019;","journal-title":"Diabetes Ther"},{"issue":"(5):","key":"key20250630091532_B32","doi-asserted-by":"crossref","first-page":"756\u2013","DOI":"10.1210\/endrev\/bnaa017","article-title":"Glycemic monitoring and management in advanced chronic kidney disease.","volume":"41","author":"Galindo","year":"2020;","journal-title":"Endocr Rev"},{"issue":"(5S):","key":"key20250630091532_B33","first-page":"S1\u2013","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease.","volume":"102","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group.","year":"2022;","journal-title":"Kidney Int"},{"issue":"(3):","key":"key20250630091532_B34","doi-asserted-by":"crossref","first-page":"381\u2013","DOI":"10.7326\/M22-2904","article-title":"Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 clinical practice guideline update.","volume":"176","author":"Navaneethan","year":"2023;","journal-title":"Ann Intern Med"},{"issue":"(8):","key":"key20250630091532_B35","doi-asserted-by":"crossref","first-page":"78.","DOI":"10.1007\/s11886-019-1168-y","article-title":"Role of and recent evidence for antiplatelet therapy in prevention of cardiovascular disease in diabetes.","volume":"21","author":"Sharma","year":"2019;","journal-title":"Curr Cardiol Rep"},{"key":"key20250630091532_B36","doi-asserted-by":"crossref","first-page":"7.","DOI":"10.1186\/s13098-019-0403-4","article-title":"Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management.","volume":"11:","author":"Sulaiman","year":"2019;","journal-title":"Diabetol Metab Syndr"},{"issue":"(3):","key":"key20250630091532_B37","first-page":"47.","article-title":"Nutritional management of idiopathic nephrotic syndrome in pediatric age.","volume":"11","author":"Lella","year":"2023;","journal-title":"Med Sci (Basel)"},{"key":"key20250630091532_B38","doi-asserted-by":"crossref","first-page":"1868.","DOI":"10.3389\/fphys.2018.01868","article-title":"Nephrotic syndrome: oedema formation and its treatment with diuretics.","volume":"9:","author":"Gupta","year":"2019;","journal-title":"Front Physiol"},{"key":"key20250630091532_B39","doi-asserted-by":"crossref","first-page":"55\u2013","DOI":"10.1016\/B978-0-12-800270-4.00002-X","article-title":"Micronutrient status in type 2 diabetes: a review.","volume":"71:","author":"Kaur","year":"2014;","journal-title":"Adv Food Nutr Res"},{"issue":"(2):","key":"key20250630091532_B40","doi-asserted-by":"crossref","first-page":"331\u2013","DOI":"10.1002\/ncp.10622","article-title":"Pediatric nephrotic syndrome: pharmacologic and nutrition management.","volume":"36","author":"Hampson","year":"2021;","journal-title":"Nutr Clin Pract"},{"issue":"(5):","key":"key20250630091532_B41","doi-asserted-by":"crossref","first-page":"469\u2013","DOI":"10.1159\/000320749","article-title":"Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure.","volume":"32","author":"Kelly","year":"2010;","journal-title":"Am J Nephrol"},{"issue":"(6):","key":"key20250630091532_B42","first-page":"45\u2013","article-title":"Diabetic nephropathy: risk factors of rapid progression of renal failure.","volume":"71","author":"Shestakova","year":"1999;","journal-title":"Ter Arkh"},{"issue":"(4):","key":"key20250630091532_B43","doi-asserted-by":"crossref","first-page":"363\u2013","DOI":"10.1111\/1744-9987.12079","article-title":"Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.","volume":"17","author":"Ekart","year":"2013;","journal-title":"Ther Apher Dial"},{"issue":"(5):","key":"key20250630091532_B44","first-page":"263\u2013","article-title":"Management of diabetes during corticosteroid therapy.","volume":"29","author":"Jannot-Lamotte","year":"2000;","journal-title":"Presse Med"},{"issue":"(21):","key":"key20250630091532_B45","doi-asserted-by":"crossref","first-page":"11857.","DOI":"10.3390\/ijms222111857","article-title":"Recent advances in diabetic kidney diseases: from kidney injury to kidney fibrosis.","volume":"22","author":"Hung","year":"2021;","journal-title":"Int J Mol Sci"},{"key":"key20250630091532_B46","doi-asserted-by":"crossref","first-page":"630617.","DOI":"10.3389\/fphar.2021.630617","article-title":"Improving the dysregulation of FoxO1 activity is a potential therapy for alleviating diabetic kidney disease.","volume":"12:","author":"Wang","year":"2021;","journal-title":"Front Pharmacol"},{"key":"key20250630091532_B47","doi-asserted-by":"crossref","first-page":"6782\u2013","DOI":"10.18632\/aging.202537","article-title":"The role of CDX2 in renal tubular lesions during diabetic kidney disease.","volume":"13:","author":"Liu","year":"2021;","journal-title":"Aging"},{"key":"key20250630091532_B48","doi-asserted-by":"crossref","first-page":"76\u2013","DOI":"10.1016\/j.abb.2014.12.012","article-title":"The Keap1-Nrf2 system and diabetes mellitus.","volume":"566:","author":"Uruno","year":"2015;","journal-title":"Arch Biochem Biophys"},{"key":"key20250630091532_B49","doi-asserted-by":"crossref","first-page":"1997\u2013","DOI":"10.1681\/ASN.2009010019","article-title":"Wnt\/beta-catenin signaling promotes podocyte dysfunction and albuminuria.","volume":"20:","author":"Dai","year":"2009;","journal-title":"J Am Soc Nephrol"},{"key":"key20250630091532_B50","doi-asserted-by":"crossref","first-page":"e141279.","DOI":"10.1172\/JCI141279","article-title":"DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.","volume":"131:","author":"Cao","year":"2021;","journal-title":"J Clin Investig"},{"key":"key20250630091532_B51","doi-asserted-by":"crossref","first-page":"143\u2013","DOI":"10.1093\/cvr\/cvs283","article-title":"FOXO1 impairs whereas statin protects endothelial function in diabetes through reciprocal regulation of Kruppel-like factor 2.","volume":"97:","author":"Lee","year":"2013;","journal-title":"Cardiovasc Res"},{"key":"key20250630091532_B52","doi-asserted-by":"crossref","first-page":"17846\u2013","DOI":"10.1074\/jbc.M109.076992","article-title":"Kruppel-like factor 4 promotes differentiation by transforming growth factor-beta receptor-mediated Smad and p38 MAPK signaling in vascular smooth muscle cells.","volume":"285:","author":"Li","year":"2010;","journal-title":"J Biol Chem"},{"key":"key20250630091532_B53","first-page":"3843\u2013","article-title":"Overexpression of KLF5 inhibits puromycin-induced apoptosis of podocytes.","volume":"18:","author":"Li","year":"2018;","journal-title":"Mol Med Rep"},{"key":"key20250630091532_B54","doi-asserted-by":"crossref","first-page":"1347\u2013","DOI":"10.1172\/JCI77084","article-title":"Kruppel-like factor 6 regulates mitochondrial function in the kidney.","volume":"125:","author":"Mallipattu","year":"2015;","journal-title":"J Clin Investig"},{"key":"key20250630091532_B55","doi-asserted-by":"crossref","first-page":"631\u2013","DOI":"10.1159\/000355743","article-title":"Kruppel-like factor 15 modulates renal interstitial fibrosis by ERK\/MAPK and JNK\/MAPK pathways regulation.","volume":"37:","author":"Gao","year":"2013;","journal-title":"Kidney Blood Press Res"},{"key":"key20250630091532_B56","doi-asserted-by":"crossref","first-page":"e9828.","DOI":"10.15252\/emmm.201809828","article-title":"A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction.","volume":"11:","author":"Lin","year":"2019;","journal-title":"EMBO Mol Med"},{"key":"key20250630091532_B57","doi-asserted-by":"crossref","first-page":"6693\u2013","DOI":"10.1093\/nar\/gkw258","article-title":"Protection of CpG islands from DNA methylation is DNA-encoded and evolutionarily conserved.","volume":"44:","author":"Long","year":"2016;","journal-title":"Nucleic Acids Res"},{"key":"key20250630091532_B58","doi-asserted-by":"crossref","first-page":"409\u2013","DOI":"10.1016\/j.kint.2019.02.020","article-title":"Aberrant DNA methylation of mTOR pathway genes promotes inflammatory activation of immune cells in diabetic kidney disease.","volume":"96:","author":"Chen","year":"2019;","journal-title":"Kidney Int"},{"key":"key20250630091532_B59","doi-asserted-by":"crossref","first-page":"1321\u2013","DOI":"10.1042\/CS20190372","article-title":"Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.","volume":"133:","author":"Guo","year":"2019;","journal-title":"Clin Sci"},{"key":"key20250630091532_B60","doi-asserted-by":"crossref","first-page":"253\u2013","DOI":"10.1007\/978-3-319-22671-2_13","article-title":"MicroRNAs in Diabetic Kidney Disease.","volume":"888:","author":"Chung","year":"2015;","journal-title":"Adv Exp Med Biol"},{"issue":"(2):","key":"key20250630091532_B61","doi-asserted-by":"crossref","first-page":"S39\u2013","DOI":"10.1053\/j.ajkd.2013.10.048","article-title":"Markers of and risk factors for the development of diabetic kidney disease.","volume":"63","author":"MacIssac","year":"2014;","journal-title":"Am J Kidney Dis"},{"key":"key20250630091532_B62","doi-asserted-by":"crossref","first-page":"150\u2013","DOI":"10.1016\/j.diabres.2017.12.007","article-title":"Potential serum biomarkers for early detection of diabetic nephropathy.","volume":"136:","author":"Motawi","year":"2018;","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:15:44Z","timestamp":1751274944000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-72-10-58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.59556\/japi.72.0687"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0687","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}